Evidence map›Paper›PMID 41808445›Full record

ArticleBioinformatics (Oxford, England)2026

Predicting antibody-antigen affinity with a dual-level representation model.

Ziyang Wang, Yu Zhang, Youli Zhang, Jianwei Huang, Xiaoli Lu, Xiaoping Min, Shengxiang Ge, Jun Zhang, Ningshao Xia

Abstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ziyang WangInstitute of Artificial Intelligence, Xiamen University, Xiamen, 361102, China.ORCID 0000-0003-1656-0638
Yu ZhangInstitute of Artificial Intelligence, Xiamen University, Xiamen, 361102, China.ORCID 0009-0001-1816-9539
Youli ZhangState Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, School of Public Health; National Institute of Diagnostics and Vaccine Development in Infectious Diseases; National Innovation Platform for Industry-Education Integration in Vaccine Research; NMPA Key Laboratory for Research and Evaluation of Infectious Disease Diagnostic Technology, Xiamen University, Xiamen, 361102, China.
Jianwei HuangInstitute of Artificial Intelligence, Xiamen University, Xiamen, 361102, China.ORCID 0009-0009-8629-9229
Xiaoli LuInformation and Networking Center, Xiamen University, Xiamen, 361102, China.
Xiaoping MinState Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, School of Public Health; National Institute of Diagnostics and Vaccine Development in Infectious Diseases; National Innovation Platform for Industry-Education Integration in Vaccine Research; NMPA Key Laboratory for Research and Evaluation of Infectious Disease Diagnostic Technology, Xiamen University, Xiamen, 361102, China.
Shengxiang GeState Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, School of Public Health; National Institute of Diagnostics and Vaccine Development in Infectious Diseases; National Innovation Platform for Industry-Education Integration in Vaccine Research; NMPA Key Laboratory for Research and Evaluation of Infectious Disease Diagnostic Technology, Xiamen University, Xiamen, 361102, China.
Jun ZhangState Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, School of Public Health; National Institute of Diagnostics and Vaccine Development in Infectious Diseases; National Innovation Platform for Industry-Education Integration in Vaccine Research; NMPA Key Laboratory for Research and Evaluation of Infectious Disease Diagnostic Technology, Xiamen University, Xiamen, 361102, China.ORCID 0000-0002-6601-9180
Ningshao XiaState Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, School of Public Health; National Institute of Diagnostics and Vaccine Development in Infectious Diseases; National Innovation Platform for Industry-Education Integration in Vaccine Research; NMPA Key Laboratory for Research and Evaluation of Infectious Disease Diagnostic Technology, Xiamen University, Xiamen, 361102, China.

Funding

Fundamental Research Funds for the Central Universities 20720250004Major Science and Technology Project of Fujian Provincial Health Commission 2021ZD01006National Natural Science Foundation of Chin 62272399National Natural Science Foundation of Chin U24A20742Noncommunicable Chronic Diseases-National Science and Technology Major Project 2023ZD0501001
6 · The paper itself

Abstract

motivationProtein language models are critical for modeling antibody-antigen interactions, yet sequence-based affinity prediction remains a key challenge, particularly when structural data are scarce. Existing methods often struggle to fully exploit sequence information, limiting their applicability across diverse antibody formats such as single-domain antibodies (sdAbs).

resultsWe propose dual-level protein representation for affinity prediction (DLP-Affinity), a dual-level deep learning framework for accurate sequence-based affinity prediction. It leverages two complementary modules: residue-to-residue to capture local interface contacts, and global stochastic projection embedding to represent global protein properties. Utilizing a fine-tuned protein language model, our approach achieves state-of-the-art performance on the general AB-Bind dataset (reducing mean absolute error by up to 20.9%) and delivers highly competitive results on the sdAb-DB dataset. This provides a robust tool for sequence-based antibody affinity prediction. AVAILABILITY AND IMPLEMENTATION: The source code and datasets for DLP-Affinity are freely available at https://github.com/Zy-Wang-bit/DLP_Affinity and archived on Zenodo at https://doi.org/10.5281/zenodo.18437656.

Indexed as

AntibodiesAntibody AffinityAntigensComputational BiologyDeep LearningAntibodiesAntigens

Identifiers

PMID41808445
PMCPMC13070686

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.